Craif (Location: Bunkyo-ku, Tokyo, CEO: Ryuichi Onose, hereinafter referred to as “Craif”) is pleased to announce that it presented a joint study result regarding ovarian cancer with Shinichi Tate, Associate Professor at Chiba University Hospital, at “ESMO Congress 2021,” held online in Paris, France from September 16th to September 21st. With the result of this study, Craif will aim to implement an ovarian cancer test using urinary miRNA.

The ESMO Congress 2021 will showcase the latest advances in cancer treatment and provide an opportunity for delegates from all over the world to exchange ideas and opinions in an interactive environment.
[Dates] September 16th - September 21st, 2021
[Venue] Paris/France (online), Paris Expo Porte des Versailles
[Official Website] https://www.esmo.org/meetings/esmo-congress-2021
